COLLEGE BUSINESS & TECHNOLOGY PARK, DUBLIN 15, L2
Earnings Release
CEO Sigurdur Olafsson Signs New Employment Agreement Until 2028
News, Material Contracts
Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
Reports Third Quarter 2025 Financial Results
Mallinckrodt plc Changes Fiscal Year End to December 31
Reg. FD
Investor Presentation
Notice of Late Filing for Annual Report
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus Filed Pursuant to Rule 425
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
S-8 POS
Specialized Disclosure Report
Correspondence